Moreover, the induction of mitochondrial activity by thyroid hormone or docosahexenoic acid in breast cancer cells can accentuate the efficacy of chemotherapy [17,29], while reduced mitochondrial activity or enhanced glycolytic activity correlates with poor prognosis [16,30]. This evidence concerns the gene TG and breast cancer.